Endothelin-receptor antagonism: the future is bright

Lancet. 2008 Jun 21;371(9630):2061-2. doi: 10.1016/S0140-6736(08)60895-8.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antihypertensive Agents / therapeutic use*
  • Bosentan
  • Endothelin Receptor Antagonists*
  • Humans
  • Hypertension, Pulmonary / classification
  • Hypertension, Pulmonary / drug therapy*
  • Randomized Controlled Trials as Topic
  • Severity of Illness Index
  • Sulfonamides / therapeutic use*

Substances

  • Antihypertensive Agents
  • Endothelin Receptor Antagonists
  • Sulfonamides
  • Bosentan